盐酸沙拉沙星(sarafloxacin)在鸡体内的药动学和生物利用度

2组健康艾维因肉鸡各 8只 ,体重 (1.6 6± 0 .11) kg,研究了对其单剂量 (10 mg/kg,以沙拉沙星碱计 )静注和口服盐酸沙拉沙星后的药动学及其生物利用度 ,用高效液相色谱法测定血清中沙拉沙星的浓度。结果表明 :静注盐酸沙拉沙星溶液后 ,血清药物浓度经时过程符合无吸收因素二室模型 ,其消除半衰期 (t1 / 2β)、总体清除率 (CLB)、表观分布容积 (Vd)和药时曲线下面积 (AU C)分别为 (2 .6 78± 0 .5 0 6 ) h、(1.339± 0 .35 1) L/kg· h、(5 .15 9± 1.5 5 4) L/kg和(7.85 3± 1.731) mg/L· h;口服盐酸沙拉沙星片后 ,药时数据呈有吸收因素一室模型 ,其吸收和消除半衰期 (t1 / 2 ka,t1 / 2 ke)、血清峰浓度 (Cmax)、达峰时间 (Tmax)和药时曲线下面积 (AUC)分别为 (0 .2 87± 0 .117) h、(5 .381± 1.44 6 ) h、(0 .478± 0 .196 ) mg/L、(1.2 2 9± 0 .439) h和 (4 .0 6 0± 1.178) m g/L· h,生物利用度为 (5 1.70± 15 .0 0 ) %。     

Antibacterial activity of TiO2 nanotube arrays on periodontal pathogens before and after loaded with minocycline hydrochloride

AIM:To investigate the effects of titanium dioxide (TiO₂) nanotube arrays on the early adhesion behavior of Porphyromonas gingivalis (Pg), Tannerella forsythia (Tf) and Actinobacillus actinomycetemcomitans (Aa) before and after loaded with minocycline hydrochloride (MN). METHODS:TiO₂ nanotube arrays were prepared by ano-dization and loaded with MN. Titanium slices were divided into 3 groups according to different treatment methods:pure polishing titanium (Ti) group, TiO₂ nanotube titanium (TiO₂) group, and MN (120 μg) TiO₂ nanotube titanium (MN TiO₂) group. The antibacterial properties of the titanium tablets were evaluated by the bacteriostasis test.RESULTS:The Ti had no antibacterial activity. The antibacterial activity of TiO₂ to Aa, Pg and Tf was poor, with only about 20% of antibacterial rate after 4 h. After loaded with MN, its antibacterial activity was enhanced, and the antibacterial rate was up to 77% after 4 h.CONCLUSION:No antibacterial activity in the Ti group was observed. If TiO₂ nanotube arrays were formed on the surface and MN was loaded, the antibacterial activity on periodontal pathogens was stronger.     

Pharmacokinetics of articaine hydrochloride and its metabolite articainic acid after subcutaneous administration in red deer (Cervus elaphus)

AIM: To develop and validate a simple and sensitive method using liquid chromatography-mass spectrometry (LC-MS) for quantification of articaine, and its major metabolite articainic acid, in plasma of red deer (Cervus elaphus), and to investigate the pharmacokinetics of articaine hydrochloride and articainic acid in red deer following S/C administration of articaine hydrochloride as a complete ring block around the antler pedicle.

METHODS: The LC-MS method was validated by determining linearity, sensitivity, recovery, carry-over and repeatability. Articaine hydrochloride (40?mg/mL) was administered S/C to six healthy male red deer, at a dose of 1?mL/cm of pedicle circumference, as a complete ring block around the base of each antler. Blood samples were collected at various times over the following 12 hours. Concentrations in plasma of articaine and articainic acid were quantified using the validated LC-MS method. Pharmacokinetic parameters of articaine and articainic acid were estimated using non-compartmental analysis.

RESULTS: Calibration curves were linear for both articaine and articainic acid. The limits of quantifications for articaine and articainic acid were 5 and 10?ng/mL, respectively. Extraction recoveries were >72% for articaine and >68% for articainic acid. After S/C administration as a ring block around the base of each antler, mean maximum concentrations in plasma (C_max) of articaine were 1,013.9 (SD 510.1) ng/mL, detected at 0.17 (SD 0.00) hours, and the C_max for articainic acid was 762.6 (SD 95.4) ng/mL at 0.50 (SD 0.00) hours. The elimination half-lives of articaine hydrochloride and articainic acid were 1.12 (SD 0.17) and 0.90 (SD 0.07) hours, respectively.

CONCLUSIONS AND CLINICAL RELEVANCE: The LC-MS method used for the quantification of articaine and its metabolite articainic acid in the plasma of red deer was simple, accurate and sensitive. Articaine hydrochloride was rapidly absorbed, hydrolysed to its inactive metabolite articainic acid, and eliminated following S/C administration as a ring block in red deer. These favourable pharmacokinetic properties suggest that articaine hydrochloride should be tested for efficacy as a local anaesthetic in red deer for removal of velvet antlers. Further studies to evaluate the safety and residues of articaine hydrochloride and articainic acid are required before articaine can be recommended for use as a local anaesthetic for this purpose.     

加味当归四逆壳聚糖喷膜剂的研制

研制加味当归四逆壳聚糖喷膜剂,并且制定生产工艺和质量标准。试验采用水煎法提取处方药材;通过正交试验确定壳聚糖盐酸盐、PVPK-30以及乙醇成膜材料的最佳配比;按照药典相关规定,采用紫外分光光度法测定每瓶总黄酮的含量。成膜材料的最佳配比为壳聚糖盐酸盐1%,3%PVPK-30和40%乙醇。通过TLC鉴定样品含有阿魏酸和芍药苷成分。质量标准中性状为澄清有清凉气味的红棕色液体,总黄酮的含量1.83 mg/mL。以处方为219 mg/mL中药复方,1%的壳聚糖盐酸盐,3%的PVPK-30以及40%的乙醇制备出加味当归四逆壳聚糖喷膜剂,且制定质量标准中样品含有阿魏酸和芍药苷并且每瓶总黄酮含量满足1.83 mg/mL。     

土霉素在鸡蛋中的残留消除研究

研究临床使用常规剂量及养殖环节加大盐酸土霉素可溶性粉剂量后其在鸡蛋中的残留消除规律。对产蛋期蛋鸡分别给予500 mg/L和667 mg/L 50%盐酸土霉素可溶性粉,集中饮水给药,每日1次,连续5 d。分别采集停药后1～12 d的鸡蛋样品,采用UPLC-MS/MS测定鸡蛋中土霉素的残留量。按上述方法给药后,低、高剂量组分别在停药第1天和停药第2天达到土霉素残留量最高。低、高剂量组的最高残留量分别为142. 72、82. 84μg/kg,均低于国家规定的最高残留限量(200μg/kg),不会造成土霉素残留超标。本试验通过研究土霉素可溶性粉在鸡蛋中的残留情况,确定弃蛋期前后土霉素残留量,以期为蛋鸡产蛋期安全用药,保障食品安全提供科学依据。     

对碘量法测定日粮、肠道食糜及排泄物中半胱胺盐酸盐含量的改进研究

试验旨在探讨碘量法测定日粮、食糜及排泄物中半胱胺盐酸盐(cysteamine hydrochloride,CSH)含量的改进方法,为评估包膜CSH在动物胃肠道内释放过程中CSH的定量提供参考。试验分3部分:试验一:检验包膜CSH的上样量对碘标准液消耗量的线性关系,以确定碘量法检验包膜产品的准确度,采用单因素完全随机设计,CSH的上样量设6个水平,分别为28.28、113.12、226.24、339.36、452.48和565.61mg;试验二:考察H2SO4预处理对消除日粮、食糜和排泄物对碘量法测定CSH含量的影响,采用单因素完全随机设计,日粮、十二指肠食糜、空肠食糜、回肠食糜及排泄物样品中CSH(试剂级)的含量均设3个水平,即30、100和300mg/2g,形成15个含有CSH的样品,H2SO4溶液(6mol/L)设3个水平,即0.1、0.5和1mL,每个处理设3个重复;试验三:考察传统碘量法与试验二建立的改进方法在测定日粮、食糜及排泄物中包膜CSH含量的差异,采用两样本试验设计,日粮、十二指肠食糜、空肠食糜、回肠食糜及排泄物中CSH的含量均设28.73、84.84、141.47和200.56mg/2g。结果表明:①CSH的上样量对碘标准液消耗量及CSH测定值均呈显著的线性关系(P<0.01,R2=0.9999)。②在含有CSH的日粮中,H2SO4溶液处理后由碘量法测定的CSH质量对实际质量的回归均符合Y=X(P>0.05)。在含有CSH的十二指肠食糜和回肠食糜中,所有H2SO4溶液处理下CSH质量对实际质量的回归均不符合Y=X(P<0.05),但0.5和1.0mL比0.1mL H2SO4溶液处理使测定值更接近实际值。在含有CSH的空肠食糜及排泄物中,0.5和1.0mL H2SO4溶液处理使测定值对实际值的回归符合Y=X(P>0.05),而0.1mL H2SO4溶液处理下CSH测定值显著低于实际值(P<0.01)。③在含有CSH的日粮、十二指肠食糜、空肠食糜、回肠食糜及排泄物样品中,常规方法测定的CSH对实际质量均偏离Y=X(P<0.05),而1.0mL H2SO4溶液处理后的测值对实际质量均符合Y=X(P>0.05)。由此可见,采用适量H2SO4溶液进行处理后,可以排除日粮、食糜及排泄物对CSH测定的干扰。     

HPLC-PDA方法同时检测黄连解毒散中非法添加的对乙酰氨基酚和盐酸溴己新

为同时检测黄连解毒散中非法添加的对乙酰氨基酚和盐酸溴己新,以十八烷基键合硅胶为填充剂,1%冰醋酸溶液(用三乙胺调剂p H值至4.0)为流动相A,甲醇为流动相B,进行梯度洗脱,流速为1.0 m L/min,波长扫描范围为210~400 nm,柱温25℃,建立了HPLC-PAD检测方法,并采用峰纯度检查和光谱相似度检查辅助对照品比对方法,对非法添加药物进行确证。结果显示,对乙酰氨基酚和盐酸溴己新的回收率分别为98.6%和99.4%,RSD分别为0.6%和0.2%;线性方程分别为y=43408x-401.96,R2=1和y=14331x-1682.4,R2=1;检测限分别为1和5 mg/g;定量限分别为2和10 mg/g。本方法简洁、灵敏、可靠,可同时对黄连解毒散中非法添加的对乙酰氨基酚和盐酸溴己新违禁药物进行定性和定量检测。     

Aqueous humor and plasma concentrations of a compounded 0.2% solution of terbinafine following topical ocular administration to normal equine eyes

Objective To determine the transcorneal penetration and systemic absorption of a compounded 0.2% terbinafine solution following repeated topical administration to normal equine eyes. Sample population Six healthy adult horses with normal ocular examinations. Procedures One eye of each horse received 0.2 mL of a compounded 0.2% terbinafine solution every 4 h for seven doses. During the 1 h following administration of the final dose, multiple peripheral blood samples were obtained, and a single aqueous humor (AH) sample was collected at the end of the hour. AH and plasma concentrations of terbinafine were determined using high pressure liquid chromatography (HPLC). Stability of the formulation was assessed with HPLC analysis over a 14‐day time period. Results Terbinafine was not detected in the AH or plasma of any horse at any time point. No signs of ocular irritation or systemic toxicity were noted in any horse at any time point. The solution was stable over 14 days. Conclusion Topical ocular administration of compounded 0.2% terbinafine solution does not result in detectable AH or plasma levels following administration to normal equine eyes, suggesting its use for deep corneal or intraocular fungal infections in equine ophthalmology may be limited.     

HPLC法测定盐酸小檗碱预混剂的含量

采用HPLC法测定盐酸小檗碱预混剂中盐酸小檗碱含量。色谱柱为Agilent ZORBAXSB-C18柱(3.9mm×150mm,4μm),流动相为0.02mol/L磷酸二氢钾溶液(用磷酸调pH为2.5)-乙腈(70∶30,V/V),检测波长346nm,流速1.0mL/min,柱温为30℃,保留时间约6.2min。盐酸小檗碱浓度在5~80μg/mL范围内,峰面积与浓度呈良好的线性关系(r2=0.9999)。平均回收率99.5%,RSD为0.4%。该方法适用于检测盐酸小檗碱预混剂。